The smoking cessation medications varenicline and bupropion do not appear to increase the incidence of serious neuropsychiatric side effects compared to placebo, according to a study published in The Lancet today.
Apr 23, 2016
0
237
For some people receiving methadone for treatment of opioid use disorder (OUD), the co-use of opioids and stimulants such as cocaine is an issue. Now, a new study led by Johns Hopkins Medicine researchers found that bupropion, ...
Mar 15, 2023
0
17
Despite public health advances, tobacco use remains one of the most common, preventable and costly health problems in the United States and worldwide. In the U.S., more deaths—an estimated 480,000 each year—are attributable ...
Feb 8, 2022
0
45
Despite preliminary supporting evidence that the dopaminergic agent bupropion might improve sexual desire for female cancer survivors, the NRG Oncology CC004 clinical trial determined that bupropion did not improve outcomes ...
Dec 10, 2021
0
17
A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix in the US and Champix elsewhere in the world) does not appear ...
Feb 20, 2020
0
1
Only about 7 percent of older adults who smoked used a prescription smoking cessation medication within 90 days after being discharged from a hospital following a heart attack, according to a study published by JAMA Cardiology.
Jul 19, 2017
0
0
Among patients unresponsive to an antidepressant medication, adding the antipsychotic aripiprazole modestly increased the likelihood of remission from depression compared to switching to the antidepressant bupropion, according ...
Jul 11, 2017
0
0
A new study led by Assistant Medical Professor Philip Smith of The City College of New York's Sophie Davis Biomedical Education/CUNY School of Medicine, and conducted in collaboration with researchers at Yale University and ...
Jul 13, 2016
0
0
Group Health researchers have found that bupropion (marketed as Wellbutrin) is the only antidepressant that tends to be linked to long-term modest weight loss.
Apr 20, 2016
0
21
(HealthDay)—Extended pre-quit bupropion is associated with reduced smoking behavior during the pre-quit period and improved short-term abstinence rates, according to a study published online Jan. 14 in Nicotine & Tobacco ...
Mar 6, 2015
0
32
